Medication use leading to emergency department visits for adverse drug events in older adults.
about
Nurses transforming health care using genetics and genomicsUse of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesRoutine deprescribing of chronic medications to combat polypharmacyClopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice?The new oral anticoagulants and the future of haemostasis laboratory testingThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityEmergency department visits for antibiotic-associated adverse eventsAdverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugsEffects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort studyInappropriate prescribing and adverse drug events in older peopleCooperation between geriatricians and general practitioners for improved pharmacotherapy in home-dwelling elderly people receiving polypharmacy - the COOP Study: study protocol for a cluster randomised controlled trial.Estimation of the warfarin dose with clinical and pharmacogenetic data.Preventing the preventable: reducing rehospitalizations through coordinated, patient-centered discharge processesPredictors of high-risk prescribing among elderly Medicare Advantage beneficiariesFrom pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006.Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillationCharacteristics of ambulatory anticoagulant adverse drug events: a descriptive studyTreatment considerations for elderly and frail patients with neuropathic painAdverse drug events leading to emergency department visits at an eye hospital: A brief report.The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).Expectations, validity, and reality in pharmacogenetics.The Medicare drug benefit (Part D) and treatment of heart failure in older adults.Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategiesHypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE).Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients.The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables.Identifying risk of readmission in hospitalized elderly adults through inpatient medication exposure.Does medical student knowledge of anticoagulation differ by future intended practice?Warfarin dosing in patients with impaired kidney functionPrescribing quality in older veterans: a multifocal approachManaging medications in clinically complex elders: "There's got to be a happy medium".An unintended consequence of electronic prescriptions: prevalence and impact of internal discrepancies.A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingThe occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database.Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population.Cardiovascular pharmacogenomics and individualized drug therapyResearch priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.Adoption of clinical decision support in multimorbidity: a systematic review.
P2860
Q24630531-A655E722-17EB-48F1-9404-CB78806E25C5Q24657307-A0680037-0319-4652-9108-BA67CCED4EF2Q26775802-FAD24CE9-2DF9-454C-9859-1B2E73F88457Q26823542-5E827AEE-2358-468D-9F1A-B2EC6B27EF89Q27022461-B2667EC1-2C51-4FB8-9BA8-9B54E4F5F0A8Q28080256-E788B593-B5FF-4553-90F0-2011294AA954Q28290501-A32F1F1E-6FA2-486F-AEF6-1BA1E07EF4CDQ28476135-AF0E8597-354B-4075-8E58-A8812996742AQ28544992-2D182A09-386A-4D85-A9C4-1EE8657786AEQ30486013-B4F9371D-735E-4C37-96C2-E2AAC7613858Q30843968-2BB7368E-5D64-4908-B63A-13C1FDE04674Q33410725-AE667B87-D87D-4EF8-8142-C4809EA92369Q33454254-B8B7AF84-FF5B-4229-846C-A2AD3EB8915FQ33596373-4DFDFD66-7199-4A4F-B3F4-3BB24731BC24Q33712474-8884F402-8828-4CB9-8FD6-7A9146922DFEQ33714864-9E2D82A0-5EC9-41E9-B0E4-9973C6FCD18AQ33745957-3B7CC49E-1695-4BDA-A092-A56CF90BAF57Q33747265-8D544993-AD32-42D8-9A22-61AC0E515EA4Q33775010-65F139F8-67D2-466C-B492-051587977CBEQ33911757-D2C9FEB8-592B-435E-ABBD-FDCC9B6C165AQ33926313-9262A2A4-E333-4900-B326-4B506D893082Q33967679-B91BB06F-EB1C-43C9-962C-4EC63991B71BQ34016237-B1D9B9C5-EDE8-4CB4-B933-6BE4E9CA7DB4Q34050711-2907F891-BB6C-4ED0-9F5A-C22060DB46C3Q34074885-50A952BF-DAB7-46A1-BDE0-4A3B1CCAF221Q34086508-327A3ABC-1114-4289-8B60-947F535110A2Q34146227-56083227-D152-4C25-9315-5255C431E178Q34158488-F3A0EF5E-4894-4095-A127-198219D629AFQ34238435-A5F6B2BA-E9E8-4D9F-AB9A-428621C99C14Q34246616-4EBD5ADB-DA75-4FEE-A9D3-CE020DF0AB8DQ34311242-8EBF5417-328E-4E66-891C-3A3D72099950Q34371633-A15F44E8-E3C1-4DE6-90C7-F9E5F809E40FQ34637462-45E36272-4A2D-4B13-A887-4596FFE7A30EQ34656118-032F54FE-7262-4C0A-826B-68FD5644F463Q34802690-FC1ADDBD-F373-4EBE-B4CC-1C110F248B81Q34971776-7870D5F5-A13A-4080-9D3D-96F683B32D4BQ35014979-4A8AC027-6462-4D9F-BD85-E8A8893929BFQ35025518-18C5AF2F-44A1-431B-9BA3-AB7D2F0DED98Q35051538-9163B4A2-1DFB-49F0-B52F-AED954056DF9Q35054286-976E31C9-E203-4DA0-86AA-806532C8E2B7
P2860
Medication use leading to emergency department visits for adverse drug events in older adults.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Medication use leading to emer ...... e drug events in older adults.
@en
Medication use leading to emer ...... e drug events in older adults.
@nl
type
label
Medication use leading to emer ...... e drug events in older adults.
@en
Medication use leading to emer ...... e drug events in older adults.
@nl
prefLabel
Medication use leading to emer ...... e drug events in older adults.
@en
Medication use leading to emer ...... e drug events in older adults.
@nl
P2093
P1476
Medication use leading to emer ...... e drug events in older adults.
@en
P2093
Chesley L Richards
Daniel S Budnitz
Nadine Shehab
Scott R Kegler
P304
P356
10.7326/0003-4819-147-11-200712040-00006
P407
P577
2007-12-01T00:00:00Z